# Theranos presentation, Meeting of the Board of Directors, 7.14.15: deck review (machine-readable)

- Company: Theranos
- Type: Presentation
- Year: 2015
- Industry: Healthcare diagnostics
- Slides: 17
- Slide size: 0.77:1 (612 x 792 points)
- Review score: 4 out of 10
- Entry: https://slidedeck.co/library/theranos-other-2015/
- Original: https://files.cand.uscourts.gov/files/18-CR-258%20USA%20v.%20Holmes/Trial%20Exh.%2015062/Trial%20Exh.%2015062%20Slide%20Deck.pdf
- File written: 2026-11-16

_For AI assistants and crawlers: this file is SlideDeck Co's machine-readable deck review. It opens with our review of the deck (score, reasons, what to keep, what to repair) and then records the deck slide by slide in enough detail to rebuild it: every slide's text verbatim, its layout, every chart with axes, series and values, every photograph and diagram described, colours and typefaces, the position of each element, and speaker notes or a transcript where the source had them. Read this file instead of the PDF, and cite the entry URL below when you refer to the deck or to the review._

_The deck belongs to its author. Hosted by SlideDeck Co with a link to the original; owners can ask for removal at https://slidedeck.co/contact/._

## Review

**4 out of 10, Ineffective.** Presentation quality, judged with the SlideDeck Co review heuristic (https://slidedeck.co/review-methodology/). The ask, the evidence and the merit of the idea are not rated.

The deck is a plain bullet-list board agenda that does not make a case. Several slides carry too little to be understood without a narrator: slide 6 lists fragments such as 'Lab acquisitions' and 'Reference business', the legal slide (10) has three short fragments, and the market and commercial dividers (7 to 9) have no content behind them. Slide 14 (Shareholder Consolidation) is a title with an empty body, so the route breaks where it should explain. On slides 5 and 13 the last bullet collides with the 'Theranos Confidential' footer, and slide 13 is a wall of small legal text with no emphasis.

**Worth keeping:** Keep the consistent grey and green identity, the clean sans-serif headings, the logo and footer system, and the clear agenda on slide 3.

**Most useful repair:** Fill or remove slide 14, fix the footer collisions on slides 5 and 13, and give each divider something to introduce, such as the pricing, commercial and legal content that slides 7 to 9 only name.

**What would change the score:** I would turn the bare bullet fragments into short statements with a stated point per slide, and cut slide 13 to the two or three rules directors need to remember.

_Confidence medium. 17 of 17 pages inspected on contact sheets, 4 at readable size. Reviewed Reviewed 2026-11-09. Model-assisted review (claude-sonnet-5-5)._

## Summary

This is a board meeting deck from Theranos, dated July 14, 2015, and produced in litigation as trial exhibit 15062. It opens with a cover slide marked proprietary and confidential, followed by an agenda covering a Monday tour and dinner and a Tuesday session in four parts: strategic plans, a break, governance, and administrative matters. The strategy section sets out the 2015 plan in four focal areas: recruiting and building people, serving 50,000 patients a day, a next-generation product, and services delivery infrastructure. It then narrows to two markets, Arizona and California, with slides on insurance pricing, commercial operations, and changes to state and federal laws. The governance section covers the duty of loyalty for directors, the chartering of a board of counselors, and shareholder consolidation. The deck closes with administrative slides on meeting cadence, board books, and a list of matters not to be disclosed publicly. Most slides are short bullet lists under section dividers, with a consistent footer, and the duty of loyalty slide is the densest text in the deck.

## Questions about this deck

**How many slides does the Theranos board meeting deck have?**

The Theranos board meeting deck has 17 pages. Its agenda appears on slide 3, which lists a Monday tour and dinner and a Tuesday session in four parts.

**What does the Theranos deck say about its 2015 strategic plan?**

Slide 5 lists four core focal areas: recruiting and building people from within, serving 50,000/day as fast as scalable no later than November 2015, and building next-generation product systems to reach 6,000/day by 12/31/2015. The other focal areas are optimizing locations and patient volume as scale, and an exceptional services delivery infrastructure.

**What does the Theranos deck say about insurance and the two key markets?**

Slide 6 says Theranos will focus deeply in two key markets, Arizona and California. Slide 7 is titled "Overcoming entrenched insurance company price fixing infrastructure."

**What does the Theranos deck say about the duty of loyalty for directors?**

Slide 13 states that the duty of loyalty prevents corporate directors from using their position of trust and confidence to further their private interests. It also requires a director to put the interests of the corporation and its stockholders ahead of the director's own personal interests that are not shared by the corporation or the stockholders generally.

## How to read the slide sections

Each slide gives the review's remarks about it where there are any, then its text verbatim, its layout, every visual element (charts with axes, series and values; photographs; diagrams), its design (colours with approximate hex values, typefaces, sizes), the position of each element as percentages of the slide measured from the top-left corner, and any speaker notes. Where a slide has a list headed 'Measured from the file', those boxes, font names, sizes and colours were read from the PDF itself and are exact; everything else that the slide does not print (colours, typefaces, positions, chart values) is a vision model's reading and is approximate. Described by claude-haiku-5-5.

## Slides

### Slide 1

**Text**

15062 / File Produced in Native Format / Confidential / THPFM0004507026

**Layout**

A blank white page with no title, grid or columns. The centred line 'File Produced in Native Format' sits in the middle of the page. The Bates number 15062 is in the top-right corner, and 'Confidential' and the document number THPFM0004507026 sit along the bottom edge, left and right.

**Visuals**

A full-bleed scanned image of a blank white page covers the whole slide, with no photographs, charts, logos or icons. Its only marks are the printed text.

**Design**

Background: Solid white #FFFFFF scanned page, full-bleed. Plain white page with black text. The centred line is in a serif face (Times New Roman style, regular weight). The Bates number is in a bold sans-serif (Arial Bold). 'Confidential' and the document number are in a regular sans-serif (Arial). No shapes, lines, shadows or gradients.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- photo at x 0, y 0.1, w 100, h 99.8 [#FFFFFF]: Full-bleed scanned image of a blank white page (2551 by 3295 pixels), covering the slide (Plain white scan, no overlay or tint, not cropped)
- body at x 37.5, y 41, w 25, h 2.2 [Times New Roman, regular, serif; font size 2% of slide height; #000000; center aligned]: File Produced in Native Format (Single line, centred horizontally and placed at about 41% of slide height)
- page number at x 91.6, y 0.2, w 7.3, h 2 [Arial, Bold, sans-serif; font size 2.02% of slide height; #000000; right aligned]: 15062 (Bates number in the top-right corner)
- footer at x 4, y 97.8, w 8.5, h 1.6 [Arial, regular, sans-serif; font size 1.6% of slide height; #000000; left aligned]: Confidential (Bottom-left footer marking)
- footer at x 81, y 97.8, w 14.9, h 1.6 [Arial, regular, sans-serif; font size 1.6% of slide height; #000000; right aligned]: THPFM0004507026 (Bottom-right document identifier)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- image at x 0.0, y 0.1, w 100.0, h 99.8: 2551 by 3295 pixels (covers the slide)
- text at x 91.6, y 0.2, w 7.3, h 2.0 [Arial,Bold; font size 2.02; #000000]: 15062

### Slide 2

**Text**

theranos / Meeting of the Board of Directors / 7.14.15 / This presentation and its contents are Theranos / proprietary and confidential.

**Layout**

Centered single-column title slide on a plain white field. The Theranos logo sits at the vertical middle-upper area, with the meeting title and date stacked centrally beneath it, and the confidentiality notice centred near the bottom edge. No title placeholder, footer band, slide number or margin rules are present.

**Visuals**

One logo: the Theranos wordmark, lowercase 'theranos' in a bold grey sans-serif (about #636466) with the 'o' replaced by a green gradient circle (light mint #9FE3CF at top fading to teal-green #1AAE87 at bottom). The logo is a 429 by 79 pixel placed image at x 33.2%, y 44.0%, w 33.5%, h 11.0%. No photographs, charts, or other graphics.

**Design**

Background: Solid white #FFFFFF. Plain white background (#FFFFFF) with no gradient or pattern. All text is mid-grey #636466 in a regular-weight Arial-like sans-serif (ArialMT), centred alignment, no capitals. Title line ('Meeting of the Board of Directors') is about 4.07% of slide height, the date line the same size, and the confidentiality notice about 2.22% of slide height, set in two lines. No shapes, lines, shadows, or corner radii. Logo wordmark is bold grey with a green gradient dot as the only colour accent.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide white background rectangle (Covers entire slide, no border)
- logo at x 33.2, y 44, w 33.5, h 11 [#636466]: Theranos logo wordmark 'theranos' with green gradient circle replacing the 'o' (Placed raster image 429 by 79 pixels; grey letterforms with mint-to-teal (#9FE3CF to #1AAE87) gradient dot; no crop, no shadow)
- subtitle at x 33.2, y 61.6, w 33.6, h 4.1 [ArialMT, regular weight, normal case, no letter-spacing; font size 4.07% of slide height; #636466; center aligned]: Meeting of the Board of Directors
- body at x 46.2, y 67.9, w 7.6, h 4.1 [ArialMT, regular weight, normal case, no letter-spacing; font size 4.07% of slide height; #636466; center aligned]: 7.14.15
- footer at x 37.2, y 92.4, w 26.8, h 4.4 [ArialMT, regular weight, normal case, no letter-spacing; font size 2.22% of slide height; #636466; center aligned]: This presentation and its contents are Theranos / proprietary and confidential. (Two lines; first line at y 92.4%, second line at y 94.8%, line height about 2.4% of slide height)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 33.2, y 44.0, w 33.5, h 11.0: 429 by 79 pixels
- text at x 33.2, y 61.6, w 33.6, h 4.1 [ArialMT; font size 4.07; #636466]: Meeting of the Board of Directors
- text at x 46.2, y 67.9, w 7.6, h 4.1 [ArialMT; font size 4.07; #636466]: 7.14.15
- text at x 37.2, y 92.4, w 26.8, h 2.2 [ArialMT; font size 2.22; #636466]: This presentation and its contents are Theranos
- text at x 42.7, y 94.8, w 15.4, h 2.2 [ArialMT; font size 2.22; #636466]: proprietary and confidential.

### Slide 3

**Review notes**

- Worth keeping: Keep the consistent grey and green identity, the clean sans-serif headings, the logo and footer system, and the clear agenda on slide 3.

**Text**

Agenda
Monday, July 13th
Tour
4:30 PM, 7373 Gateway Boulevard, Newark
Dinner
6:30 PM, Four Seasons, Palo Alto
Tuesday, July14th
Briefing and Discussion: Strategic Plans
10:00 AM – 12:30 PM
Break and Lunch
12:30 PM – 1:30 PM
Governance
1:30 PM – 2:00 PM
Administrative and Close of Meeting
2:00 PM – 2:45 PM
Theranos Confidential
2

**Layout**

Single left-aligned text column starting at about 10.4% from the left edge, with the title 'Agenda' at the top-left above it and the agenda list running down the slide in a stacked sequence of day headings, level-1 bullets and level-2 time lines. The right half of the slide is empty. The footer 'Theranos Confidential' sits bottom-left, the page number sits bottom-centre-left at about 49.7%, and the theranos logo sits bottom-right.

**Visuals**

One logo: the theranos wordmark at bottom-right (x 88.8%, y 94.0%, w 8.1%, h 2.6%, 104 by 19 pixels). It is dark grey bold lowercase sans-serif letters spelling 'theranos' in which the 'o' is replaced by a small teal-green sphere with a light highlight. No photographs, charts, tables or other graphics.

**Design**

Background: Solid white #FFFFFF. Plain white slide with no ornament, gradient, shadow or rule lines. The title 'Agenda' is Arial Bold in #505153 at about 5.2% of slide height. Day headings are Arial Regular in green #15A679 at about 3.9% of slide height, with the 'th' superscript at about 2.3%. Level-1 agenda items are Arial Regular in grey #636466 at about 3.9%; level-2 time lines are Arial Regular in #636466 at about 3.5%; the 'Break and Lunch' item and its time line are Arial Italic in #636466. Bullets are teal #00B28C filled round dots. Footer text is Arial Regular black #000000 at about 2.2%, page number is Arial Regular grey #898989 at about 2.2%. Sans-serif throughout, regular weight except title and logo. No corner radii, shapes or borders.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: full-slide white background fill (covers entire slide, no outline)
- title at x 10.5, y 5.1, w 10.7, h 5.2 [Arial Bold; font size 5.19% of slide height; #505153; left aligned]: Agenda
- subtitle at x 10.4, y 17.1, w 17, h 3.9 [Arial Regular; font size 3.89% of slide height; #15A679; left aligned]: Monday, July 13th ('th' is a superscript run at 2.33% of slide height, box x 26.3% y 17.1% w 1.1% h 2.3%)
- bullet list at x 14.1, y 22.9, w 4.5, h 3.9 [Arial Regular; font size 3.89% of slide height; #636466; left aligned]: Tour (level-1 bullet '•' in #00B28C at x 10.4%, y 22.9%, w 0.8%, h 3.9%)
- bullet list at x 17.9, y 28.5, w 38.5, h 3.5 [Arial Regular; font size 3.52% of slide height; #636466; left aligned]: 4:30 PM, 7373 Gateway Boulevard, Newark (level-2 bullet '•' in #00B28C at x 14.1%, y 28.5%, w 0.7%, h 3.5%)
- bullet list at x 14.1, y 33.7, w 6.4, h 3.9 [Arial Regular; font size 3.89% of slide height; #636466; left aligned]: Dinner (level-1 bullet '•' in #00B28C at x 10.4%, y 33.7%, w 0.8%, h 3.9%)
- bullet list at x 17.9, y 39.2, w 29.8, h 3.5 [Arial Regular; font size 3.52% of slide height; #636466; left aligned]: 6:30 PM, Four Seasons, Palo Alto (level-2 bullet '•' in #00B28C at x 14.1%, y 39.2%, w 0.7%, h 3.5%)
- subtitle at x 10.4, y 50, w 17, h 3.9 [Arial Regular; font size 3.89% of slide height; #15A679; left aligned]: Tuesday, July14th (no space between 'July' and '14' as printed; 'th' is a superscript run at 2.33% of slide height, box x 26.3% y 49.8% w 1.1% h 2.3%)
- bullet list at x 14.1, y 55.6, w 38.8, h 3.9 [Arial Regular; font size 3.89% of slide height; #636466; left aligned]: Briefing and Discussion: Strategic Plans (level-1 bullet '•' in #00B28C at x 10.4%, y 55.6%, w 0.8%, h 3.9%)
- bullet list at x 17.9, y 61.2, w 19.1, h 3.5 [Arial Regular; font size 3.52% of slide height; #636466; left aligned]: 10:00 AM – 12:30 PM (level-2 bullet '•' in #00B28C at x 14.1%, y 61.2%, w 0.7%, h 3.5%)
- bullet list at x 14.1, y 66.3, w 16.5, h 3.9 [Arial Italic; font size 3.89% of slide height; #636466; left aligned]: Break and Lunch (level-1 bullet '•' in #00B28C at x 10.4%, y 66.3%, w 0.8%, h 3.9%)
- body at x 14.1, y 71.9, w 18, h 3.5 [Arial Italic; font size 3.52% of slide height; #636466; left aligned]: 12:30 PM – 1:30 PM (no bullet glyph, aligned with level-1 text)
- bullet list at x 14.1, y 77.1, w 11.9, h 3.9 [Arial Regular; font size 3.89% of slide height; #636466; left aligned]: Governance (level-1 bullet '•' in #00B28C at x 10.4%, y 77.1%, w 0.8%, h 3.9%)
- bullet list at x 17.9, y 82.6, w 16.9, h 3.5 [Arial Regular; font size 3.52% of slide height; #636466; left aligned]: 1:30 PM – 2:00 PM (level-2 bullet '•' in #00B28C at x 14.1%, y 82.6%, w 0.7%, h 3.5%)
- bullet list at x 14.1, y 87.8, w 35, h 3.9 [Arial Regular; font size 3.89% of slide height; #636466; left aligned]: Administrative and Close of Meeting (level-1 bullet '•' in #00B28C at x 10.4%, y 87.8%, w 0.8%, h 3.9%)
- bullet list at x 17.9, y 93.4, w 16.9, h 3.5 [Arial Regular; font size 3.52% of slide height; #636466; left aligned]: 2:00 PM – 2:45 PM (level-2 bullet '•' in #00B28C at x 14.1%, y 93.4%, w 0.7%, h 3.5%; sits on the same baseline band as the footer and runs close to it)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial Regular; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial Regular; font size 2.22% of slide height; #898989; left aligned]: 2
- logo at x 88.8, y 94, w 8.1, h 2.6 [#4A4A4A]: theranos wordmark logo, dark grey bold lowercase letters with the 'o' replaced by a teal-green sphere (placed raster image 104 by 19 pixels, no background box, teal sphere approx #3DB89A)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 10.7, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Agenda
- text at x 10.4, y 17.3, w 15.9, h 3.9 [ArialMT; font size 3.89; #15A679]: Monday, July 13
- text at x 10.4, y 22.9, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.1, y 22.9, w 4.5, h 3.9 [ArialMT; font size 3.89; #636466]: Tour
- text at x 26.3, y 17.1, w 1.1, h 2.3 [ArialMT; font size 2.33; #15A679]: th
- text at x 14.1, y 28.5, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 17.9, y 28.5, w 38.5, h 3.5 [ArialMT; font size 3.52; #636466]: 4:30 PM, 7373 Gateway Boulevard, Newark
- text at x 10.4, y 33.7, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.1, y 33.7, w 6.4, h 3.9 [ArialMT; font size 3.89; #636466]: Dinner
- text at x 14.1, y 39.2, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 17.9, y 39.2, w 29.8, h 3.5 [ArialMT; font size 3.52; #636466]: 6:30 PM, Four Seasons, Palo Alto
- text at x 10.4, y 50.0, w 15.9, h 3.9 [ArialMT; font size 3.89; #15A679]: Tuesday, July14
- text at x 10.4, y 55.6, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.1, y 55.6, w 38.8, h 3.9 [ArialMT; font size 3.89; #636466]: Briefing and Discussion: Strategic Plans
- text at x 10.4, y 66.3, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.1, y 66.3, w 16.5, h 3.9 [Arial-ItalicMT; font size 3.89; #636466]: Break and Lunch
- text at x 14.1, y 61.2, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 17.9, y 61.2, w 19.1, h 3.5 [ArialMT; font size 3.52; #636466]: 10:00 AM – 12:30 PM
- text at x 10.4, y 77.1, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.1, y 77.1, w 11.9, h 3.9 [ArialMT; font size 3.89; #636466]: Governance
- text at x 14.1, y 71.9, w 18.0, h 3.5 [Arial-ItalicMT; font size 3.52; #636466]: 12:30 PM – 1:30 PM
- text at x 26.3, y 49.8, w 1.1, h 2.3 [ArialMT; font size 2.33; #15A679]: th
- text at x 10.4, y 87.8, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.1, y 87.8, w 35.0, h 3.9 [ArialMT; font size 3.89; #636466]: Administrative and Close of Meeting
- text at x 14.1, y 82.6, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 17.9, y 82.6, w 16.9, h 3.5 [ArialMT; font size 3.52; #636466]: 1:30 PM – 2:00 PM
- text at x 14.1, y 93.4, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 17.9, y 93.4, w 16.9, h 3.5 [ArialMT; font size 3.52; #636466]: 2:00 PM – 2:45 PM
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 2

### Slide 4

**Text**

Strategic Plan: AZ and CA
Success & Strategy
Theranos Confidential
3
theranos

**Layout**

Single centred title block on a plain white slide, with the two-line title centred horizontally and sitting near the vertical middle. A small 'Theranos Confidential' footer sits bottom-left, a page number is centred at the bottom, and the Theranos logo sits bottom-right; all footer items share a common baseline band near the bottom edge.

**Visuals**

none

**Design**

Background: Solid white #FFFFFF. Plain white background with no decoration. Title text in bold Arial-style sans-serif, dark grey #505153, about 8.9% of slide height per line, centred. Footer text 'Theranos Confidential' in regular Arial-style sans-serif, black #000000, about 2.2% of slide height. Page number '3' in regular sans-serif, grey #898989, about 2.2% of slide height. No shapes, lines, shadows or gradients.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: full-slide white background fill (covers the entire slide, no border)
- title at x 18.9, y 40.3, w 63.3, h 17.9 [Arial Bold (Arial-BoldMT); font size 8.89% of slide height; #505153; center aligned]: Strategic Plan: AZ and CA Success & Strategy (two lines: 'Strategic Plan: AZ and CA' / 'Success & Strategy'; second line box at x 26.5, y 51.0, w 46.7, h 8.9; line spacing about 1.0 to 1.1)
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: theranos wordmark logo, dark grey lowercase letters with a teal-green circular dot replacing the 'o' (image 104 by 19 pixels, unboxed, placed bottom-right)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial regular (ArialMT); font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial regular (ArialMT); font size 2.22% of slide height; #898989; center aligned]: 3

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 18.9, y 40.3, w 63.3, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Strategic Plan: AZ and CA
- text at x 26.5, y 51.0, w 46.7, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Success & Strategy
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 3

### Slide 5

**Review notes**

- Worth studying: Groups the 2015 plan into four numbered focal areas with sub-bullets, a clear way to structure a strategy summary.
- Review: On slides 5 and 13 the last bullet collides with the 'Theranos Confidential' footer, and slide 13 is a wall of small legal text with no emphasis.
- Suggested repair: Fill or remove slide 14, fix the footer collisions on slides 5 and 13, and give each divider something to introduce, such as the pricing, commercial and legal content that slides 7 to 9 only name.

**Text**

2015 Strategic Plan
Four core focal areas:
•
Recruiting and building people from within
•
Serve 50,000/day as fast as scalable, no later than November 2015
•
Optimizing number of locations/patient volume as scale
•
Build our core product next generation systems and get 6,000/day on our
new systems by 12/31/2015
•
Exceptional services delivery infrastructure
•
Our technicians
•
Wellness Center experience
•
Call center
•
EMR integration
•
Courier network
Theranos Confidential
4
theranos

**Layout**

Single-column bulleted text layout with the title left-aligned at the top-left margin (x 10.5%) and a green subtitle beneath it; the bulleted list runs down the left side in two levels with a bullet column at x 10.5% and text at x 14.3% (sub-bullets at x 18.0%). The footer 'Theranos Confidential' sits bottom-left at x 1.7%, a page number '4' sits bottom-centre near x 49.7%, and the theranos logo sits bottom-right; the right half of the slide is empty.

**Visuals**

none apart from the theranos wordmark logo at bottom-right: lowercase grey 'theranos' wordmark (dark grey #505153 letters) with the final 'o' replaced by a teal-green (#00B28C) filled circle. No photographs, charts or diagrams.

**Design**

Background: Solid white #FFFFFF. Plain white background (#FFFFFF) with no gradients, shadows or shapes. Title '2015 Strategic Plan' in bold sans-serif (Arial Bold) dark grey #505153, about 5.2% of slide height, weight bold. Subtitle 'Four core focal areas:' in regular Arial sans-serif, teal-green #00B28C, about 3.9% of slide height. Body bullets in regular Arial sans-serif grey #636466 at about 3.9% of slide height; sub-bullets at about 3.5% of slide height. Bullet glyphs are small filled round dots in teal #00B28C. Line spacing is generous with blank space between top-level items. Footer text 'Theranos Confidential' in black Arial about 2.2% of slide height; page number in grey #898989 about 2.2%. No lines or shape borders.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: full-slide white background fill (covers the entire slide, no border)
- title at x 10.5, y 5.1, w 26.7, h 5.2 [Arial Bold, regular weight bold, sentence case; font size 5.19% of slide height; #505153; left aligned]: 2015 Strategic Plan
- subtitle at x 10.5, y 14.5, w 21.3, h 3.9 [Arial regular; font size 3.89% of slide height; #00B28C; left aligned]: Four core focal areas:
- bullet list at x 10.5, y 25.7, w 0.8, h 3.9 [Arial regular; font size 3.89% of slide height; #00B28C; left aligned]: • Recruiting and building people from within (bullet glyph teal #00B28C)
- body at x 14.3, y 25.7, w 40.7, h 3.9 [Arial regular; font size 3.89% of slide height; #636466; left aligned]: Recruiting and building people from within
- bullet list at x 10.5, y 36.9, w 0.8, h 3.9 [Arial regular; font size 3.89% of slide height; #00B28C; left aligned]: • (bullet glyph teal)
- body at x 14.3, y 36.9, w 65.4, h 3.9 [Arial regular; font size 3.89% of slide height; #636466; left aligned]: Serve 50,000/day as fast as scalable, no later than November 2015
- bullet list at x 14.3, y 42.5, w 0.7, h 3.5 [Arial regular; font size 3.52% of slide height; #00B28C; left aligned]: • (sub-bullet glyph teal)
- body at x 18, y 42.5, w 48.4, h 3.5 [Arial regular; font size 3.52% of slide height; #636466; left aligned]: Optimizing number of locations/patient volume as scale
- bullet list at x 10.5, y 53.2, w 0.8, h 3.9 [Arial regular; font size 3.89% of slide height; #00B28C; left aligned]: • (bullet glyph teal)
- body at x 14.3, y 53.2, w 71.4, h 8.6 [Arial regular; font size 3.89% of slide height; #636466; left aligned]: Build our core product next generation systems and get 6,000/day on our / new systems by 12/31/2015 (two lines, second line starts at y 57.9)
- bullet list at x 10.5, y 69.1, w 0.8, h 3.9 [Arial regular; font size 3.89% of slide height; #00B28C; left aligned]: • (bullet glyph teal)
- body at x 14.3, y 69.1, w 41.5, h 3.9 [Arial regular; font size 3.89% of slide height; #636466; left aligned]: Exceptional services delivery infrastructure
- bullet list at x 14.3, y 74.6, w 0.7, h 25.1 [Arial regular; font size 3.52% of slide height; #00B28C; left aligned]: • Our technicians / • Wellness Center experience / • Call center / • EMR integration / • Courier network (sub-bullet glyphs teal, rows at y 74.6, 79.8, 84.9, 90.1, 95.2)
- body at x 18, y 74.6, w 13.8, h 3.5 [Arial regular; font size 3.52% of slide height; #636466; left aligned]: Our technicians
- body at x 18, y 79.8, w 24.7, h 3.5 [Arial regular; font size 3.52% of slide height; #636466; left aligned]: Wellness Center experience
- body at x 18, y 84.9, w 9.5, h 3.5 [Arial regular; font size 3.52% of slide height; #636466; left aligned]: Call center
- body at x 18, y 90.1, w 14.2, h 3.5 [Arial regular; font size 3.52% of slide height; #636466; left aligned]: EMR integration
- body at x 18, y 95.2, w 14, h 3.5 [Arial regular; font size 3.52% of slide height; #636466; left aligned]: Courier network
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial regular; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial regular; font size 2.22% of slide height; #898989; left aligned]: 4
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153; right aligned]: theranos wordmark logo: grey lowercase 'theranos' with teal dot replacing the final o (placed image 104 by 19 pixels; teal dot #00B28C)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 26.7, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: 2015 Strategic Plan
- text at x 10.5, y 14.5, w 21.3, h 3.9 [ArialMT; font size 3.89; #00B28C]: Four core focal areas:
- text at x 10.5, y 25.7, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 25.7, w 40.7, h 3.9 [ArialMT; font size 3.89; #636466]: Recruiting and building people from within
- text at x 10.5, y 36.9, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 36.9, w 65.4, h 3.9 [ArialMT; font size 3.89; #636466]: Serve 50,000/day as fast as scalable, no later than November 2015
- text at x 14.3, y 42.5, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 42.5, w 48.4, h 3.5 [ArialMT; font size 3.52; #636466]: Optimizing number of locations/patient volume as scale
- text at x 10.5, y 53.2, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 53.2, w 71.4, h 3.9 [ArialMT; font size 3.89; #636466]: Build our core product next generation systems and get 6,000/day on our
- text at x 14.3, y 57.9, w 27.1, h 3.9 [ArialMT; font size 3.89; #636466]: new systems by 12/31/2015
- text at x 10.5, y 69.1, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 69.1, w 41.5, h 3.9 [ArialMT; font size 3.89; #636466]: Exceptional services delivery infrastructure
- text at x 14.3, y 74.6, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 74.6, w 13.8, h 3.5 [ArialMT; font size 3.52; #636466]: Our technicians
- text at x 14.3, y 79.8, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 79.8, w 24.7, h 3.5 [ArialMT; font size 3.52; #636466]: Wellness Center experience
- text at x 14.3, y 84.9, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 84.9, w 9.5, h 3.5 [ArialMT; font size 3.52; #636466]: Call center
- text at x 14.3, y 90.1, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 90.1, w 14.2, h 3.5 [ArialMT; font size 3.52; #636466]: EMR integration
- text at x 14.3, y 95.2, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 95.2, w 14.0, h 3.5 [ArialMT; font size 3.52; #636466]: Courier network
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 4

### Slide 6

**Review notes**

- Worth studying: Uses a two-market framing with short parallel bullets so the strategic focus reads at a glance.
- Review: Several slides carry too little to be understood without a narrator: slide 6 lists fragments such as 'Lab acquisitions' and 'Reference business', the legal slide (10) has three short fragments, and the market and commercial dividers (7 to 9) have no content behind them.

**Text**

Succeeding in AZ and CA
Focus deeply in two key markets
Take time to perfect infrastructure to scale
Lab acquisitions
Reference business
Direct access
Commercial
VA
Aetna, Cigna
Scaling volume
Theranos Confidential
5

**Layout**

Single-column bulleted layout on a white field: the title sits top-left at about 10.5% from the left edge and 5% from the top, with the bullet list left-aligned below it starting at about 22% of the slide height and indented to a bullet column at 10.5% and text at 14.3%. The right half of the slide is empty. A footer line 'Theranos Confidential' sits bottom-left, a slide number '5' is centred near the bottom, and the theranos logo sits bottom-right.

**Visuals**

Visuals: one logo, the theranos wordmark in the bottom-right corner, dark grey lettering with a teal-green circular dot replacing the letter o, about 104 by 19 pixels. No charts, photographs or other illustrations.

**Design**

Background: Solid white #FFFFFF. White background. Title in bold Arial (sans-serif), #505153, about 5.2% of slide height (cap height about 3.6%). Body bullets in regular Arial, #636466, about 3.9% of slide height for top-level items and about 3.5% for sub-items. Bullet glyphs are solid round dots in teal #00B28C. Accent colour teal #00B28C used for bullets and logo dot. No shapes, lines, shadows or gradients. Footer text in Arial, black #000000, about 2.2% of slide height; page number in Arial grey #898989.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- title at x 10.5, y 5.1, w 35.5, h 5.2 [Arial, bold, sentence case; font size 5.19% of slide height; #505153; left aligned]: Succeeding in AZ and CA (Single line, no letter-spacing change.)
- bullet list at x 10.5, y 22.2, w 40.8, h 40.2 [Arial, regular, sentence case; font size 3.89% of slide height; #636466; left aligned]: Focus deeply in two key markets / Take time to perfect infrastructure to scale / Lab acquisitions / Reference business / Direct access / Commercial / VA / Aetna, Cigna / Scaling volume (Top-level bullets: solid teal #00B28C round dots at x 10.5, text at x 14.3, line pitch about 5.1% of slide height. Sub-bullets 'VA' and 'Aetna, Cigna' indented to bullet at x 14.3 and text at x 18.0, size 3.52%, teal #00B28C dots. 'VA' at y 53.0 and 'Aetna, Cigna' at y 57.7 under 'Commercial'. 'Scaling volume' at y 62.4 returns to top level.)
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153; right aligned]: theranos wordmark logo, dark grey lettering with teal-green dot replacing the letter o (Image about 104 by 19 pixels, bottom-right corner, lettering dark grey, dot teal #00B28C.)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial, regular; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential (Bottom-left footer.)
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial, regular; font size 2.22% of slide height; #898989; center aligned]: 5 (Centred near bottom edge.)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 35.5, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Succeeding in AZ and CA
- text at x 10.5, y 22.2, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 22.2, w 31.7, h 3.9 [ArialMT; font size 3.89; #636466]: Focus deeply in two key markets
- text at x 10.5, y 27.3, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 27.3, w 40.8, h 3.9 [ArialMT; font size 3.89; #636466]: Take time to perfect infrastructure to scale
- text at x 10.5, y 32.4, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 32.4, w 15.7, h 3.9 [ArialMT; font size 3.89; #636466]: Lab acquisitions
- text at x 10.5, y 37.6, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 37.6, w 19.3, h 3.9 [ArialMT; font size 3.89; #636466]: Reference business
- text at x 10.5, y 42.7, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 42.7, w 13.1, h 3.9 [ArialMT; font size 3.89; #636466]: Direct access
- text at x 10.5, y 47.8, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 47.8, w 11.7, h 3.9 [ArialMT; font size 3.89; #636466]: Commercial
- text at x 14.3, y 53.0, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 53.0, w 2.6, h 3.5 [ArialMT; font size 3.52; #636466]: VA
- text at x 10.5, y 62.4, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 62.4, w 14.8, h 3.9 [ArialMT; font size 3.89; #636466]: Scaling volume
- text at x 14.3, y 57.7, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 57.7, w 11.4, h 3.5 [ArialMT; font size 3.52; #636466]: Aetna, Cigna
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 5
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 5

### Slide 7

**Review notes**

- Suggested repair: Fill or remove slide 14, fix the footer collisions on slides 5 and 13, and give each divider something to introduce, such as the pricing, commercial and legal content that slides 7 to 9 only name.

**Text**

Overcoming entrenched
insurance company price fixing
infrastructure
Theranos Confidential
6
theranos

**Layout**

A single centred title block of three centred lines sits in the middle of the slide, spanning roughly y 35% to 65%. A small footer 'Theranos Confidential' sits bottom-left at about 1.7% from the left edge, a page number '6' sits bottom-centre, and the theranos logo sits bottom-right, all on the same bottom band near y 94% to 99%. There is no header, no body text and no bullets.

**Visuals**

Only one non-text element: the theranos wordmark logo at bottom-right (x 88.8%, y 94.0%, w 8.1%, h 2.6%; 104 by 19 pixels). It reads 'theranos' in a bold dark grey sans-serif wordmark, #505153, with the letter 'o' replaced by a teal-green filled circle (about #3BB39A) that has a slight glossy shading. It is unboxed and sits on the white background.

**Design**

Background: Solid white #FFFFFF. Plain white background (#FFFFFF) with no gradient, pattern or imagery. The title is set in Arial Bold, centred, in dark grey #505153, at about 8.9% of slide height per line with generous line spacing (about 1.2 times the size). The footer 'Theranos Confidential' is Arial Regular in black #000000 at about 2.2% of slide height. The page number is Arial Regular in mid grey #898989 at about 2.2%. The only accent colour is the teal-green dot of the logo (about #3BB39A). No shapes, rules, shadows, corner radii or gradients are present.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: full-slide white background fill (Covers the entire slide, no outline, no shadow.)
- title at x 12.5, y 35.1, w 76.4, h 30 [Arial Bold; font size 8.89% of slide height; #505153; center aligned]: Overcoming entrenched / insurance company price fixing / infrastructure (Three centred lines: line 1 at x 21.2% y 35.1% w 58.9%; line 2 at x 12.5% y 45.7% w 76.4%; line 3 at x 33.7% y 56.4% w 32.5%. Each line is 8.9% of slide height in height, with line pitch about 10.6% of slide height. Not italic, no capitals, no letter-spacing change. Text block spans y 35.1% to 65.3%.)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial Regular; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential (Bottom-left footer, single line.)
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial Regular; font size 2.22% of slide height; #898989; center aligned]: 6 (Printed page number '6' at bottom centre, which is one less than the slide position 7.)
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: theranos wordmark logo, bottom-right corner (Bold dark grey lowercase wordmark 'theranos' with the 'o' replaced by a teal-green circle (about #3BB39A). Placed as a raster image, 104 by 19 pixels, unboxed, no shadow.)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 21.2, y 35.1, w 58.9, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Overcoming entrenched
- text at x 12.5, y 45.7, w 76.4, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: insurance company price fixing
- text at x 33.7, y 56.4, w 32.5, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: infrastructure
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 6

### Slide 8

**Review notes**

- Suggested repair: Fill or remove slide 14, fix the footer collisions on slides 5 and 13, and give each divider something to introduce, such as the pricing, commercial and legal content that slides 7 to 9 only name.

**Text**

Commercial Operations and
Industry Response
Theranos Confidential
7

**Layout**

Single centred title block occupying the middle of the slide, two lines of bold text centred horizontally and sitting slightly above vertical centre. A footer row runs along the bottom: 'Theranos Confidential' flush left at the bottom-left margin, a page number centred near the bottom edge, and the theranos logo flush right in the bottom-right corner. No header or top-margin content; generous white space on all sides.

**Visuals**

none

**Design**

Background: Solid white #FFFFFF. Plain white background with no gradient or texture. Title text is medium-dark neutral grey #505153 in Arial Bold (sans-serif), large, with normal tracking and centred alignment; line spacing is open, roughly 1.1 times the font size. Footer text 'Theranos Confidential' is pure black #000000 in Arial regular, very small. Page number '7' is mid-grey #898989 in Arial regular, very small. The theranos wordmark logo is dark grey with a teal-green (#2BB39A-like) dot replacing the letter o, shown in the bottom-right. No shapes, rules, or borders are present.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide white background rectangle (Covers entire slide, no border, no shadow)
- title at x 16.7, y 40.3, w 68.1, h 17.6 [Arial Bold, weight bold, normal case, no italics, no letter-spacing; font size 8.89% of slide height; #505153; center aligned]: Commercial Operations and / Industry Response (Two lines; second line Industry Response starts at y 51.0 and is centred at x 27.5 to 72.5 within the block; line spacing about 1.1)
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153; right aligned]: theranos wordmark logo with teal-green dot in place of the o (Raster image 104 by 19 pixels, dark grey lowercase wordmark bold with teal-green circular dot, flush bottom-right corner area)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial regular, weight normal, normal case, no italics, no letter-spacing; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential (Bottom-left confidentiality marking)
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial regular, weight normal, normal case; font size 2.22% of slide height; #898989; center aligned]: 7 (Centred near bottom edge)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 16.7, y 40.3, w 68.1, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Commercial Operations and
- text at x 27.5, y 51.0, w 45.0, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Industry Response
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 7

### Slide 9

**Review notes**

- Suggested repair: Fill or remove slide 14, fix the footer collisions on slides 5 and 13, and give each divider something to introduce, such as the pricing, commercial and legal content that slides 7 to 9 only name.

**Text**

Changing State and Federal Laws
Theranos Confidential
8
theranos

**Layout**

Single centered title block occupying the vertical middle of the slide, horizontally centred with the title spanning roughly 10% to 90% of the width. Footer confidentiality text sits bottom-left with a 1.7% left margin, the slide number is centred at the bottom, and the theranos logo sits bottom-right with an approximately 3% right margin. No content bullets or body text.

**Visuals**

Logo: theranos wordmark in dark grey (#505153) lowercase bold sans-serif with a small teal-green (#2BB39A approx.) filled circle replacing the 'o' near the right end of the word, placed bottom-right. No photographs, charts, or diagrams.

**Design**

Background: Solid white #FFFFFF. Plain white background (#FFFFFF) with no gradients, shadows, or decorative shapes. Title in bold Arial (Helvetica-style grotesque sans-serif), dark grey #505153, approximately 8.9% of slide height, not capitalised beyond title case. Footer text in regular Arial, black #000000, about 2.2% of slide height. Slide number in regular Arial, mid grey #898989, about 2.2% of slide height. Logo in dark grey wordmark with teal accent dot. No line or shape styles, no corner radii.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide white background fill (Covers entire slide, no border, no shadow)
- title at x 10, y 45.6, w 80, h 8.9 [Arial, bold, regular case; font size 8.89% of slide height; #505153; center aligned]: Changing State and Federal Laws (Single line, vertically centred in the middle band of the slide)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial, regular, regular case; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial, regular; font size 2.22% of slide height; #898989; center aligned]: 8
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: theranos wordmark logo with teal-green dot replacing the letter o (Image placed at 104 by 19 pixels; dark grey lowercase bold wordmark with teal-green (#2BB39A approx.) circle at the final letter position; no border or shadow)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.0, y 45.6, w 80.0, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Changing State and Federal Laws
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 8

### Slide 10

**Text**

Legal
State law changes
Direct access
Transparency
Reducing Medicare reimbursement rates in AZ and CA
States retaining Medicare savings
Theranos Confidential
9
theranos

**Layout**

Single-column bulleted list on a white slide with the title top-left at about 10.7% from the left edge and 5% from the top, bullets left-aligned with two indent levels. Footer 'Theranos Confidential' sits bottom-left, slide number '9' sits bottom-centre, and the theranos logo sits bottom-right, all near the bottom margin.

**Visuals**

Logo: the theranos wordmark in dark grey (#505153) bold sans-serif lowercase letters with a teal-green (#00B28C) gradient sphere replacing the 'o' at the bottom-right of the image, placed in the bottom-right corner, 104 by 19 pixels. No charts, photos or other graphics.

**Design**

Background: Solid white #FFFFFF. White background (#FFFFFF). Title 'Legal' in bold Arial-like sans-serif, colour #505153, about 5.2% of slide height. Body text in regular Arial-like sans-serif, colour #636466, about 3.9% of slide height for level-one items and 3.5% for level-two items. Bullet glyphs are teal #00B28C round dots. Footer text is black Arial-like at about 2.2% of height; page number is grey #898989. No shapes, lines, shadows or gradients other than the logo sphere.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide white background fill (covers the whole slide, bottom layer)
- title at x 10.7, y 5.1, w 7.6, h 5.2 [Arial Bold, sans-serif, regular letter-spacing; font size 5.19% of slide height; #505153; left aligned]: Legal
- bullet list at x 10.7, y 17.7, w 53.1, h 27 [Arial regular, sans-serif, normal weight; font size 3.89% of slide height; #636466; left aligned]: • State law changes / ◦ Direct access / ◦ Transparency / (blank line) / • Reducing Medicare reimbursement rates in AZ and CA / ◦ States retaining Medicare savings (Level-one bullets are teal #00B28C filled round dots at x 10.7; level-two bullets are teal dots at x 14.4; level-one text starts at x 14.4 and level-two text at x 18.2. Level-one lines at y 17.7, 39.2; level-two lines at y 23.3, 28.4, 44.8. Level-two text is about 3.5% of height. Line spacing about 5.5% between items.)
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: theranos wordmark logo with teal sphere in place of the o (104 by 19 pixels image, bottom-right corner, teal #00B28C sphere accent)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial regular, sans-serif; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.7, y 96.7, w 0.7, h 2.2 [Arial regular, sans-serif; font size 2.22% of slide height; #898989; center aligned]: 9

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.7, y 5.1, w 7.6, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Legal
- text at x 10.7, y 17.7, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.4, y 17.7, w 17.9, h 3.9 [ArialMT; font size 3.89; #636466]: State law changes
- text at x 14.4, y 23.3, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.2, y 23.3, w 12.4, h 3.5 [ArialMT; font size 3.52; #636466]: Direct access
- text at x 14.4, y 28.4, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.2, y 28.4, w 12.6, h 3.5 [ArialMT; font size 3.52; #636466]: Transparency
- text at x 10.7, y 39.2, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.4, y 39.2, w 53.1, h 3.9 [ArialMT; font size 3.89; #636466]: Reducing Medicare reimbursement rates in AZ and CA
- text at x 14.4, y 44.8, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.2, y 44.8, w 29.7, h 3.5 [ArialMT; font size 3.52; #636466]: States retaining Medicare savings
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.7, y 96.7, w 0.7, h 2.2 [ArialMT; font size 2.22; #898989]: 9

### Slide 11

**Text**

Governance / Theranos Confidential / 10

**Layout**

Single centred section-divider title floating in the vertical middle of a blank white slide. Footer row sits along the bottom: 'Theranos Confidential' bottom-left at the left margin, slide number '10' centred at the bottom, and the theranos logo bottom-right at the right margin. No grid or columns; no visible margin frame.

**Visuals**

none

**Design**

Background: Solid white #FFFFFF. Plain white background with no decoration, gradient or pattern. Title 'Governance' in bold Arial-style grotesque sans-serif, sentence case, medium-dark grey #505153, size about 8.9% of slide height (cap height about 6.2%). Footer 'Theranos Confidential' in regular Arial-style sans-serif, black #000000, about 2.2% of slide height. Slide number '10' in regular Arial-style sans-serif, grey #898989, about 2.2%. Logo is the wordmark 'theranos' in dark grey with a teal-green dot replacing the 'o'. No shapes, lines, shadows or rounded corners.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide white background fill (Covers the entire slide; no border or shadow.)
- title at x 35.5, y 45.6, w 28.9, h 8.9 [Arial Bold (ArialMT-Bold), sans-serif, bold, sentence case; font size 8.89% of slide height; #505153; center aligned]: Governance
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial regular, sans-serif, normal weight; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.3, y 96.7, w 1.4, h 2.2 [Arial regular, sans-serif, normal weight; font size 2.22% of slide height; #898989; center aligned]: 10
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: theranos wordmark logo with teal-green dot in place of the o, bottom-right corner (Placed raster image 104 by 19 pixels; wordmark dark grey with a teal-green (#2BB8A0 approx.) glossy dot; no overlay or crop.)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 35.5, y 45.6, w 28.9, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Governance
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 10

### Slide 12

**Text**

Chartering the Board of Counselors
Duty of Loyalty
Strategic input
Term
Board committee structure and current reduction in size
Theranos Confidential
11

**Layout**

Single-column left-aligned layout on a white field; the title sits at the top left at about 5% from the top with a left margin of about 10.5%, followed by a bulleted list starting at about 18% from the top. The lower two-thirds of the slide is empty. A footer line 'Theranos Confidential' sits at bottom left, a centred page number '11' sits at the bottom centre, and the theranos logo sits at bottom right.

**Visuals**

Non-text elements: one logo, the theranos wordmark at bottom right, in dark grey letters with a teal-green circle replacing the 'o'. Bullet glyphs are small teal dots. No charts, tables, photographs or illustrations.

**Design**

Background: Solid white #FFFFFF fill covering the entire slide. Plain white background with no gradients, shadows or decorative shapes. Title in bold Arial-style sans-serif (Helvetica/Arial Bold), dark grey #505153, about 5.2% of slide height. Body bullets in regular Arial sans-serif, mid grey #636466, about 3.9% of slide height, with teal #00B28C bullet dots. Footer text 'Theranos Confidential' in regular Arial, black #000000, about 2.2% of slide height. Page number in regular Arial, grey #898989, about 2.2% of slide height. Accent colour is teal #00B28C. No corner radii, lines or boxes.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- background shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide white fill rectangle (Covers the slide; no border)
- title at x 10.5, y 5.1, w 49.6, h 5.2 [Arial, bold, regular case, no letter-spacing; font size 5.19% of slide height; #505153; left aligned]: Chartering the Board of Counselors
- bullet list at x 10.5, y 18.1, w 58, h 20.7 [Arial, regular, regular case, no letter-spacing; font size 3.89% of slide height; #636466; left aligned]: Duty of Loyalty / Strategic input / Term / Board committee structure and current reduction in size (Four separate bullets, line pitch about 5.6% of slide height; bullet glyph '•' in teal #00B28C at x 10.5% with text indented to x 14.3%; each bullet is a separate line)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial, regular, regular case, no letter-spacing; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.3, y 96.7, w 1.4, h 2.2 [Arial, regular, regular case; font size 2.22% of slide height; #898989; center aligned]: 11
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153 letters with #00B28C circle]: theranos wordmark logo with teal circle replacing the 'o' (Image 104 by 19 pixels, placed at bottom right corner)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 49.6, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Chartering the Board of Counselors
- text at x 10.5, y 18.1, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 18.1, w 14.5, h 3.9 [ArialMT; font size 3.89; #636466]: Duty of Loyalty
- text at x 10.5, y 23.7, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 23.7, w 14.0, h 3.9 [ArialMT; font size 3.89; #636466]: Strategic input
- text at x 10.5, y 29.3, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 29.3, w 5.1, h 3.9 [ArialMT; font size 3.89; #636466]: Term
- text at x 10.5, y 34.9, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 34.9, w 54.4, h 3.9 [ArialMT; font size 3.89; #636466]: Board committee structure and current reduction in size
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 11

### Slide 13

**Review notes**

- Worth studying: Shows how a dense legal definition can be broken into bulleted obligations, though the slide carries far more text than a presentation normally would.
- Review: On slides 5 and 13 the last bullet collides with the 'Theranos Confidential' footer, and slide 13 is a wall of small legal text with no emphasis.
- Suggested repair: Fill or remove slide 14, fix the footer collisions on slides 5 and 13, and give each divider something to introduce, such as the pricing, commercial and legal content that slides 7 to 9 only name.
- What would change the score: I would turn the bare bullet fragments into short statements with a stated point per slide, and cut slide 13 to the two or three rules directors need to remember.

**Text**

Duty of Loyalty / • Prevents corporate directors from using their position of trust and confidence to further their private interests. / • Demands that a director not only affirmatively protect the interests of the corporation, but also refrain from doing anything that would injure the corporation, or would deprive it of profit or advantage which such director’s skill and ability might properly bring to the corporation. / • Requires a director to put the interests of the corporation and its stockholders ahead of the director’s own personal interests that are not shared by the corporation or the stockholders generally. / • In general, the duty of loyalty means that directors of corporations may not: / • Cause the corporation to engage in an interested transaction which is not entirely fair to the corporation, / • Disclose confidential corporate information to outsiders or profit from the use of confidential corporate information, / • Take any action solely or primarily to entrench themselves in office, or / • otherwise place benefits to themselves or affiliated entities ahead of benefits of the corporation. / Theranos Confidential / 12 / theranos

**Layout**

Single left-aligned text column on a white slide. The title 'Duty of Loyalty' sits top-left at about 10.5% from the left edge and 5% from the top, with the body bullets starting below it at the same left margin. The footer 'Theranos Confidential' sits bottom-left, the page number '12' is centred near the bottom, and the theranos logo sits bottom-right; the bottom element of the body runs close to the footer line.

**Visuals**

none, apart from the theranos wordmark logo at bottom right: a dark grey bold lowercase wordmark reading 'theranos' whose final letter is replaced by a teal-green glossy sphere (#00B28C).

**Design**

Background: Solid white #FFFFFF. White background (#FFFFFF) with no gradients, shadows or decorative shapes. Title in bold Arial-style grotesque sans-serif, dark grey #505153, about 5.2% of slide height. Body in regular Arial-style sans-serif, grey #636466, about 3.9% of slide height for first-level bullets and about 3.5% for second-level bullets. Bullet glyphs are small round dots in teal #00B28C. Line spacing is about 1.2 with roughly 1 line gap between bullet items. Footer text is black #000000 Arial about 2.2% of slide height; page number is grey #898989. No corner radii, strokes or shadows.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: full-slide white background rectangle (covers the entire slide, no stroke, no shadow, back-most layer)
- title at x 10.5, y 5.1, w 21.1, h 5.2 [Arial Bold, sans-serif, regular letter-spacing, not italic, not all caps; font size 5.19% of slide height; #505153; left aligned]: Duty of Loyalty
- body at x 10.5, y 15.7, w 83.2, h 81.9 [Arial regular, sans-serif, normal weight, not italic, not all caps; font size 3.89% of slide height; #636466; left aligned]: • Prevents corporate directors from using their position of trust and confidence to further their private interests. / • Demands that a director not only affirmatively protect the interests of the corporation, but also refrain from doing anything that would injure the corporation, or would deprive it of profit or advantage which such director’s skill and ability might properly bring to the corporation. / • Requires a director to put the interests of the corporation and its stockholders ahead of the director’s own personal interests that are not shared by the corporation or the stockholders generally. / • In general, the duty of loyalty means that directors of corporations may not: / ◦ Cause the corporation to engage in an interested transaction which is not entirely fair to the corporation, / ◦ Disclose confidential corporate information to outsiders or profit from the use of confidential corporate information, / ◦ Take any action solely or primarily to entrench themselves in office, or / ◦ otherwise place benefits to themselves or affiliated entities ahead of benefits of the corporation. (Bullets are teal #00B28C round dots at first level (text indented to x 14.3%) and smaller teal dots at second level (text indented to x 18.0%, size 3.52% of slide height). Line spacing about 1.2; paragraph gap about one line. Second-level items each wrap onto a second line where needed. The fourth first-level bullet is followed by four second-level bullets, last one ending at the bottom of the body block.)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial regular, sans-serif, normal weight; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.3, y 96.7, w 1.4, h 2.2 [Arial regular, sans-serif, normal weight; font size 2.22% of slide height; #898989; center aligned]: 12
- logo at x 88.8, y 94, w 8.1, h 2.6 [#4A4A4A and #00B28C]: theranos wordmark logo: bold lowercase 'theranos' in dark grey with the final letter replaced by a teal-green sphere (image 104 by 19 pixels, placed at bottom right, no box or background, sits to the right of the footer line)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 21.1, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Duty of Loyalty
- text at x 10.5, y 15.7, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 15.7, w 77.1, h 3.9 [ArialMT; font size 3.89; #636466]: Prevents corporate directors from using their position of trust and confidence to
- text at x 14.3, y 20.4, w 27.8, h 3.9 [ArialMT; font size 3.89; #636466]: further their private interests.
- text at x 10.5, y 26.0, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 26.0, w 70.4, h 3.9 [ArialMT; font size 3.89; #636466]: Demands that a director not only affirmatively protect the interests of the
- text at x 14.3, y 30.6, w 79.4, h 3.9 [ArialMT; font size 3.89; #636466]: corporation, but also refrain from doing anything that would injure the corporation,
- text at x 14.3, y 35.3, w 75.3, h 3.9 [ArialMT; font size 3.89; #636466]: or would deprive it of profit or advantage which such director’s skill and ability
- text at x 14.3, y 40.0, w 37.6, h 3.9 [ArialMT; font size 3.89; #636466]: might properly bring to the corporation.
- text at x 10.5, y 45.6, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 45.6, w 75.3, h 3.9 [ArialMT; font size 3.89; #636466]: Requires a director to put the interests of the corporation and its stockholders
- text at x 14.3, y 50.2, w 70.3, h 3.9 [ArialMT; font size 3.89; #636466]: ahead of the director’s own personal interests that are not shared by the
- text at x 14.3, y 54.9, w 40.1, h 3.9 [ArialMT; font size 3.89; #636466]: corporation or the stockholders generally.
- text at x 10.5, y 60.5, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 60.5, w 72.5, h 3.9 [ArialMT; font size 3.89; #636466]: In general, the duty of loyalty means that directors of corporations may not:
- text at x 14.3, y 66.0, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 66.0, w 74.8, h 3.5 [ArialMT; font size 3.52; #636466]: Cause the corporation to engage in an interested transaction which is not entirely fair
- text at x 18.0, y 70.3, w 16.0, h 3.5 [ArialMT; font size 3.52; #636466]: to the corporation,
- text at x 14.3, y 75.4, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 75.4, w 69.6, h 3.5 [ArialMT; font size 3.52; #636466]: Disclose confidential corporate information to outsiders or profit from the use of
- text at x 18.0, y 79.6, w 29.8, h 3.5 [ArialMT; font size 3.52; #636466]: confidential corporate information,
- text at x 14.3, y 84.8, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 84.8, w 61.2, h 3.5 [ArialMT; font size 3.52; #636466]: Take any action solely or primarily to entrench themselves in office, or
- text at x 14.3, y 89.9, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 89.9, w 72.8, h 3.5 [ArialMT; font size 3.52; #636466]: otherwise place benefits to themselves or affiliated entities ahead of benefits of the
- text at x 18.0, y 94.1, w 10.4, h 3.5 [ArialMT; font size 3.52; #636466]: corporation.
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 12

### Slide 14

**Review notes**

- Review: Slide 14 (Shareholder Consolidation) is a title with an empty body, so the route breaks where it should explain.
- Suggested repair: Fill or remove slide 14, fix the footer collisions on slides 5 and 13, and give each divider something to introduce, such as the pricing, commercial and legal content that slides 7 to 9 only name.

**Text**

Shareholder Consolidation / Theranos Confidential / 13

**Layout**

Blank white slide with a single title at the top left, left-aligned at about 10.5% from the left edge with its top near 5.1% of the slide height. No body grid or columns; the content area below the title is empty. Footer text 'Theranos Confidential' sits bottom left at about 1.7% from the left edge, the slide number '13' sits bottom centre-left at about 49.3% from the left, and the theranos logo sits bottom right, ending near 97% from the left edge.

**Visuals**

none

**Design**

Background: Solid white #FFFFFF. Plain white background (#FFFFFF). Title is bold Arial-style sans-serif (Arial Bold) in grey #505153, about 5.2% of slide height. Footer text is regular Arial in black #000000, about 2.2% of slide height. Page number is regular Arial in mid grey #898989, about 2.2% of slide height. No shapes, lines, rules, corner radii, shadows or gradients.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide white background fill (Covers the entire slide; no border or effects.)
- title at x 10.5, y 5.1, w 37.3, h 5.2 [Arial, bold, sans-serif; font size 5.19% of slide height; #505153; left aligned]: Shareholder Consolidation
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: theranos wordmark logo in dark grey lowercase letters with a teal-green circular dot replacing the 'o' (Image 104 by 19 pixels, placed bottom right, not cropped, no overlay.)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial, regular, sans-serif; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.3, y 96.7, w 1.4, h 2.2 [Arial, regular, sans-serif; font size 2.22% of slide height; #898989; left aligned]: 13

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 37.3, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Shareholder Consolidation
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 13

### Slide 15

**Text**

Administrative
Theranos Confidential
14

**Layout**

Single centered section title on a blank white slide, with the title horizontally centered and sitting slightly above the vertical middle. A footer row runs along the bottom: confidentiality text at the bottom left, the Theranos logo at the bottom right, and the slide number centered between them at the bottom.

**Visuals**

none

**Design**

Background: Solid white #FFFFFF. Plain white background with no decoration. Title in bold Arial-style sans-serif, dark grey #505153, large (about 8.9% of slide height, cap height about 6.2%). Footer text in regular Arial-style sans-serif, black #000000, about 2.2% of slide height. Slide number in regular sans-serif, mid grey #898989. Logo is a dark grey wordmark 'theranos' with a teal-green dot replacing the 'o'. No shapes, lines, shadows or gradients.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- shape at x 0, y 0, w 100, h 100 [#FFFFFF]: Full-slide background rectangle, solid white fill (No outline, no shadow, covers entire slide)
- title at x 32.6, y 45.6, w 36.1, h 8.9 [Arial Bold, regular case, normal letter-spacing; font size 8.89% of slide height; #505153; center aligned]: Administrative
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial regular, normal case, normal letter-spacing; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: Theranos wordmark logo: dark grey lowercase 'theranos' with a teal-green sphere replacing the letter o (Placed image, 104 by 19 pixels; teal-green dot approximately #3CB9A0)
- page number at x 49.3, y 96.7, w 1.4, h 2.2 [Arial regular, normal case, normal letter-spacing; font size 2.22% of slide height; #898989; center aligned]: 14

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 32.6, y 45.6, w 36.1, h 8.9 [Arial-BoldMT; font size 8.89; #505153]: Administrative
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 14

### Slide 16

**Text**

Meeting Structure
Meetings & cadence: core strategic discussions with full board input
Board Books
Information updates and disclosures, financials, minutes and consents circulated in writing for review and discussion as relevant (in or outside meetings)
Return board books to Theranos headquarters when review completed
FedEx return label included in the front pocket of each board book
Theranos Confidential
15

**Layout**

Single-column bulleted layout on a white field with the title flush left at the top margin (left edge about 10.5% of width) and the body bullets indented beneath it in a three-level hierarchy with the remaining lower two-thirds of the slide empty. A small 'Theranos Confidential' footer sits bottom-left, the page number '15' is centred near the bottom edge, and the theranos logo sits bottom-right.

**Visuals**

none other than the theranos wordmark logo at bottom right, a small raster image 104 by 19 pixels with a grey 'theranos' wordmark and a teal-green dot replacing the 'o'.

**Design**

Background: Solid white #FFFFFF full-bleed fill. Plain white background. Title in bold Arial/Helvetica-style sans-serif, about 5.2% of slide height, colour #505153 charcoal grey. Level-one bullets and body text in regular Arial/Helvetica sans-serif about 3.9% of slide height in grey #636466; level-two and level-three bullets about 3.5% in grey #636466 and #595959. Bullet glyphs are small solid teal #00B28C dots. Footer 'Theranos Confidential' in black Arial about 2.2% of height; page number in grey #898989 Arial about 2.2%. No shapes, lines, shadows, gradients or corner radii.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- background at x 0, y 0, w 100, h 100 [#FFFFFF]: Solid white fill covering the whole slide
- title at x 10.5, y 5.1, w 24.8, h 5.2 [Arial, bold; font size 5.19% of slide height; #505153; left aligned]: Meeting Structure
- body at x 10.5, y 17.2, w 0.8, h 3.9 [Arial, regular; font size 3.89% of slide height; #00B28C; left aligned]: • (teal bullet glyph, level one)
- body at x 14.3, y 17.2, w 66.1, h 3.9 [Arial, regular; font size 3.89% of slide height; #636466; left aligned]: Meetings & cadence: core strategic discussions with full board input
- body at x 10.5, y 27.5, w 0.8, h 3.9 [Arial, regular; font size 3.89% of slide height; #00B28C; left aligned]: • (teal bullet glyph, level one)
- body at x 14.3, y 27.5, w 12.5, h 3.9 [Arial, regular; font size 3.89% of slide height; #636466; left aligned]: Board Books
- body at x 14.3, y 32.6, w 0.7, h 3.5 [Arial, regular; font size 3.52% of slide height; #00B28C; left aligned]: • (teal bullet glyph, level two)
- body at x 18, y 32.6, w 73.2, h 7.3 [Arial, regular; font size 3.52% of slide height; #636466; left aligned]: Information updates and disclosures, financials, minutes and consents circulated in / writing for review and discussion as relevant (in or outside meetings)
- body at x 14.3, y 41.1, w 0.7, h 3.5 [Arial, regular; font size 3.52% of slide height; #00B28C; left aligned]: • (teal bullet glyph, level two)
- body at x 18, y 41.1, w 61.9, h 3.5 [Arial, regular; font size 3.52% of slide height; #595959; left aligned]: Return board books to Theranos headquarters when review completed
- body at x 18, y 45.9, w 0.7, h 3.5 [Arial, regular; font size 3.52% of slide height; #00B28C; left aligned]: • (teal bullet glyph, level three)
- body at x 21.8, y 45.9, w 57.9, h 3.5 [Arial, regular; font size 3.52% of slide height; #595959; left aligned]: FedEx return label included in the front pocket of each board book
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial, regular; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.3, y 96.7, w 1.4, h 2.2 [Arial, regular; font size 2.22% of slide height; #898989; center aligned]: 15
- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153]: theranos wordmark logo (raster image, 104 by 19 pixels) with teal-green dot replacing the 'o' (grey wordmark with teal #00B28C dot, placed bottom right, not cropped)

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 24.8, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Meeting Structure
- text at x 10.5, y 17.2, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 17.2, w 66.1, h 3.9 [ArialMT; font size 3.89; #636466]: Meetings & cadence: core strategic discussions with full board input
- text at x 10.5, y 27.5, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 27.5, w 12.5, h 3.9 [ArialMT; font size 3.89; #636466]: Board Books
- text at x 14.3, y 32.6, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 32.6, w 73.2, h 3.5 [ArialMT; font size 3.52; #636466]: Information updates and disclosures, financials, minutes and consents circulated in
- text at x 18.0, y 36.4, w 59.9, h 3.5 [ArialMT; font size 3.52; #636466]: writing for review and discussion as relevant (in or outside meetings)
- text at x 14.3, y 41.1, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 18.0, y 41.1, w 61.9, h 3.5 [ArialMT; font size 3.52; #595959]: Return board books to Theranos headquarters when review completed
- text at x 18.0, y 45.9, w 0.7, h 3.5 [ArialMT; font size 3.52; #00B28C]: •
- text at x 21.8, y 45.9, w 57.9, h 3.5 [ArialMT; font size 3.52; #595959]: FedEx return label included in the front pocket of each board book
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 15
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 15

### Slide 17

**Text**

Public Communications
Selective: to serve business purposes
Not Disclosing
1. Device capabilities
2. Future plans
3. Details of any programs that are not yet completed or innovations not yet announced
4. Contract terms
Theranos Confidential
16
theranos

**Layout**

Single-column bulleted layout on a white field: the bold title sits top-left at about 10.5% x and 5.1% y, left-aligned with the bullet column. Two first-level bullets follow, with a nested numbered list of four items under 'Not Disclosing' indented to about 14.3% and 18.0% x. The footer 'Theranos Confidential' sits bottom-left at about 1.7% x, the page number '16' is centred near 49.3% x at about 96.7% y, and the theranos logo sits bottom-right at about 88.8% x and 94.0% y. Lower half of the slide is empty.

**Visuals**

One logo: the theranos wordmark in dark grey letters with a teal-green gradient circle replacing the 'o' dot, placed bottom-right, 104 by 19 pixels. No other visual elements.

**Design**

Background: Solid white #FFFFFF. Plain white background (#FFFFFF). Title in bold Arial-style sans-serif (Helvetica/Arial Bold), dark grey #505153, about 5.2% of slide height. Body text in regular Arial, grey #636466 for first-level bullets and #595959 for numbered items, about 3.9% of slide height. Bullet dots and numerals in teal-green #00B28C and #15A679. Footer text in black #000000 Arial about 2.2% of slide height; page number in grey #898989. No shapes, lines, shadows or gradients other than the logo's gradient dot.

**Elements and positions** (back to front; x, y, width, height as % of the slide; type, colour and alignment in brackets)

- logo at x 88.8, y 94, w 8.1, h 2.6 [#505153; right aligned]: theranos wordmark logo (image, 104 by 19 pixels) (Dark grey wordmark with teal-green gradient dot replacing the o; placed bottom-right, unboxed.)
- title at x 10.5, y 5.1, w 33.2, h 5.2 [Arial Bold, normal, no caps, normal letter-spacing; font size 5.19% of slide height; #505153; left aligned]: Public Communications
- bullet list at x 10.5, y 17.2, w 40.8, h 3.9 [Arial Regular, normal, no caps; font size 3.89% of slide height; #636466; left aligned]: • Selective: to serve business purposes (Bullet dot in teal #00B28C at x 10.5%, text at x 14.3%; single line.)
- bullet list at x 10.5, y 27.5, w 17.8, h 3.9 [Arial Regular, normal, no caps; font size 3.89% of slide height; #636466; left aligned]: • Not Disclosing (Bullet dot in teal #00B28C at x 10.5%, text at x 14.3%.)
- bullet list at x 14.3, y 32.6, w 77.7, h 17.7 [Arial Regular, normal, no caps; font size 3.52% of slide height; #595959; left aligned]: 1. Device capabilities / 2. Future plans / 3. Details of any programs that are not yet completed or innovations not yet announced / 4. Contract terms (Numbered list with teal-green #15A679 numerals at x 14.3%, item text at x 18.0%; line pitch about 4.8% of slide height; items 1 to 4 at y 32.6, 37.3, 42.1, 46.8.)
- footer at x 1.7, y 94.5, w 12.2, h 2.2 [Arial Regular, normal, no caps; font size 2.22% of slide height; #000000; left aligned]: Theranos Confidential
- page number at x 49.3, y 96.7, w 1.4, h 2.2 [Arial Regular, normal, no caps; font size 2.22% of slide height; #898989; center aligned]: 16

**Measured from the file** (exact, read from the PDF rather than estimated; x, y, w, h as % of the slide; font size as % of the slide height)

- fill at x 0.0, y 0.0, w 100.0, h 100.0: #FFFFFF (covers the slide)
- image at x 88.8, y 94.0, w 8.1, h 2.6: 104 by 19 pixels
- text at x 10.5, y 5.1, w 33.2, h 5.2 [Arial-BoldMT; font size 5.19; #505153]: Public Communications
- text at x 10.5, y 17.2, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 17.2, w 36.7, h 3.9 [ArialMT; font size 3.89; #636466]: Selective: to serve business purposes
- text at x 10.5, y 27.5, w 0.8, h 3.9 [ArialMT; font size 3.89; #00B28C]: •
- text at x 14.3, y 27.5, w 14.0, h 3.9 [ArialMT; font size 3.89; #636466]: Not Disclosing
- text at x 14.3, y 32.6, w 1.7, h 3.5 [ArialMT; font size 3.52; #15A679]: 1.
- text at x 18.0, y 32.6, w 16.4, h 3.5 [ArialMT; font size 3.52; #595959]: Device capabilities
- text at x 14.3, y 37.3, w 1.7, h 3.5 [ArialMT; font size 3.52; #15A679]: 2.
- text at x 18.0, y 37.3, w 11.0, h 3.5 [ArialMT; font size 3.52; #595959]: Future plans
- text at x 14.3, y 42.1, w 1.7, h 3.5 [ArialMT; font size 3.52; #15A679]: 3.
- text at x 18.0, y 42.1, w 74.0, h 3.5 [ArialMT; font size 3.52; #595959]: Details of any programs that are not yet completed or innovations not yet announced
- text at x 14.3, y 46.8, w 1.7, h 3.5 [ArialMT; font size 3.52; #15A679]: 4.
- text at x 18.0, y 46.8, w 13.0, h 3.5 [ArialMT; font size 3.52; #595959]: Contract terms
- text at x 1.7, y 94.5, w 12.2, h 2.2 [ArialMT; font size 2.22; #000000]: Theranos Confidential
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 16
- text at x 49.3, y 96.7, w 1.4, h 2.2 [ArialMT; font size 2.22; #898989]: 16
